SMG

Business Context and Reporting Period

Company: The Scotts Miracle-Gro Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 28, 2008 (Third Quarter of Fiscal 2008)
Business Overview: A leading manufacturer and marketer of consumer branded lawn and garden care products, professional horticulture products, and lawn care services (Scotts LawnService). The company operates in North America, Europe, and other international markets. It serves as the exclusive agent for Monsanto's consumer Roundup business.

Key Financial Metrics

Material Changes vs. Prior Period

• Significant Decline in Profitability: Net income dropped 82.6% in the third quarter and 84.5% for the nine-month period compared to the prior year. This is primarily driven by a non-cash impairment charge and product recall costs.
• Impairment Charge: The company recorded a $123.3 million non-cash charge for impairment of goodwill, indefinite-lived tradenames, and long-lived assets. This was triggered by a significant decline in the company's stock price, which reduced the market value of invested capital to approximately 60% of the metric used in the previous annual testing.
• Product Registration and Recall Costs: Costs related to product recalls and registration issues totaled $10.2 million for the quarter and $41.0 million for the nine months. These costs reduced income from operations and included inventory write-downs and sales reversals.
• Margin Compression: Gross profit margins declined due to increased commodity costs and the impact of recall-related costs. Operating margins fell from 20.7% to 8.0% in the third quarter.
• Cash Flow: Operating cash flow turned negative ($39.5 million used) for the nine months ended June 28, 2008, compared to $62.2 million provided in the prior year. This was due to higher accounts receivable and inventory levels.

Guidance, Outlook, Risks, and Unusual Items

• Product Registration Investigation: The company is under a criminal investigation by the USEPA and USDOJ regarding unregistered or improperly labeled pesticide products. An employee allegedly circumvented policies. The company expects total costs for recalls and known registration issues to range from $55 million to $60 million, excluding potential fines or penalties which are currently not estimable.
• Impairment Finalization: The $123.3 million impairment charge includes an estimate for goodwill. Management anticipates finalizing the required Step 2 goodwill impairment evaluation in the fourth quarter of fiscal 2008, which may result in an updated charge.
• Debt and Liquidity: Following a 2007 recapitalization that returned $750 million to shareholders, the company carries significant debt ($2.15 billion credit facilities). Management expects to remain in compliance with leverage ratio covenants for the remainder of fiscal 2008.
• Outlook: Management expects SG&A expenses to be up 4% to 5% on a full-year basis. The company notes that the product registration issues may negatively impact future demand and brand reputation.

Investor Verification Checklist

• Impairment Finality: Verify if the goodwill impairment charge is updated in the Q4 2008 filing following the Step 2 evaluation.
• Regulatory Penalties: Monitor for announcements regarding civil or criminal fines from the USEPA/USDOJ investigation, as these are currently excluded from the $55-$60 million cost estimate.
• Brand Impact: Assess the long-term impact of the product recalls on sales volume and retailer relationships, particularly for the Ortho brand.
• Debt Covenants: Confirm continued compliance with the leverage ratio covenant (scheduled to decrease to 4.25 on Sept 30, 2008) given the reduced earnings.
• Commodity Costs: Track the trajectory of commodity costs to determine if gross margin compression is a temporary or structural issue.